320 related articles for article (PubMed ID: 9211570)
1. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
König F; Wolfersdorf M
Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
Becker T; Struck M; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
[TBL] [Abstract][Full Text] [Related]
3. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
[TBL] [Abstract][Full Text] [Related]
4. RIMA: a safe concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Roth M; Guelfi JD
Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
[TBL] [Abstract][Full Text] [Related]
7. [Moclobemide in the long-term treatment of depressed patients].
Carl G; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
[TBL] [Abstract][Full Text] [Related]
8. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
Rosan TA; Mesones HL; Brengio F
Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
[TBL] [Abstract][Full Text] [Related]
9. Reversible monoamine oxidase-A inhibitors in resistant major depression.
Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
Versiani M; Nardi AE; Mundim FD; Alves AB
J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
[TBL] [Abstract][Full Text] [Related]
11. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of moclobemide in therapy-resistant depression].
Andriushchenko AV; Kolesnikov DB
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):34-7. PubMed ID: 9819886
[TBL] [Abstract][Full Text] [Related]
13. Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature.
Schöpf J
Pharmacopsychiatry; 1989 Sep; 22(5):174-82. PubMed ID: 2682691
[TBL] [Abstract][Full Text] [Related]
14. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
[TBL] [Abstract][Full Text] [Related]
15. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
16. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
Feighner JP; Herbstein J; Damlouji N
J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide--placebo-controlled trials.
Silverstone T
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
[TBL] [Abstract][Full Text] [Related]
18. Acute therapy of depression.
Bech P
J Clin Psychiatry; 1993 Aug; 54 Suppl():18-27; discussion 28. PubMed ID: 8253702
[TBL] [Abstract][Full Text] [Related]
19. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
[TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
Laux G; Classen W; Sofic E; Becker T; Riederer P; Lesch KP; Struck M; Beckmann H
J Neural Transm Suppl; 1990; 32():189-95. PubMed ID: 2089089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
